Trial intelligence / Profile preview

Randomized phase 1 trial of local and systemic reactions to an antimicrobial gel

RBR-6srzwwmPhase 1Recruiting

Sponsor
Universidade Federal de Alagoas
Start
Nov 2021
Countries
1
01

Overview

Phase 1, randomised, open-label trial in adverse drug reaction (ADR), sponsored by Universidade Federal de Alagoas. Primary endpoints: Local reaction to repeated open application of antimicrobial gel and Systemic reaction to antimicrobial gel. Started Nov 2021; status: recruiting.

02

Conditions

adverse drug reaction (ADR)

Beyond the preview

Go deeper on RBR-6srzwwm.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6srzwwm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call